The Differences Between Suspicious Lynch and Sporadic Dmmr Colorectal Cancers

G. Liu,W. Huang,R. Liu,Z. Pan,P. Ding

DOI: https://doi.org/10.1093/annonc/mdw370.115

IF: 51.769

2016-01-01

Annals of Oncology

Abstract:Few studies have systematically compared the difference between germline and sporadic dMMR colorectal cancers on clinical-pathological features, prognosis, lymphocytic reactions, somatic mutation frequencies and neoantigen burdens. We retrospectively collected dMMR colorectal patients identified by postoperative immunohistochemistry screening. According to genetic test or clinical-pathological criterias, patients were then grouped as suspicious Lynch or sporadic dMMR. We compared the clinico-pathologic and prognostic differences between the two groups. By evaluating the four components of lymphocytic reaction {i.e., Crohn's-like reaction (CRO), immunoreactions in the invasive margin (IM), in the tumour stroma (TS) and cancer center (CC)} and counting CD3 + /CD4 + /CD8 + /Foxp3+ tumor-infiltrating lymphocytes, we investigated their immune response and lymphocyte subgroup differences. By whole exome sequencing and neoantigen detection pipeline, we contrasted their discrepancies on mutational frequencies and neoantigen burdens. 213 of the 381 dMMR pts were grouped: 94 sporadic dMMR and 119 suspicious Lynch. Sporadic dMMR patients were significantly older (P < 0.001), had more tumors proximal to splenic flexure (P < 0.001) and with poor differentiation (P = 0.003). The OS rate was higher in suspicious Lynch group (P = 0.006), after adjustment for ages and chemotherapies, the differences still remained significant (P = 0.076). The scores of CRO (P =0.013), IM (P = 0.044) and total immunoreactions (P = 0.036) of suspicious Lynch group is significantly higher. The number of CD3 +, CD4 +, CD8+ lymphocytes in CC, CD3 +, CD4 +, FoxP3+ lymphocytes in TS, CD3 +, FoxP3+ lymphocytes in IM of suspicious Lynch patients were significantly more. There were also more somatic mutations and neoantigen burdens in suspicious Lynch group compared to sporadic dMMR group, with significant difference (357/pt vs 60/pt, P = 0.015; 538/pt vs 91/pt, P = 0.049). There were more somatic mutations and neoantigens in suspicious Lynch patients and causing their more intense immunoreactions, which might benefit their survival.